155 related articles for article (PubMed ID: 3552016)
1. Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia.
Hendy-Ibbs P; Cox H; Evan GI; Watson JV
Br J Cancer; 1987 Mar; 55(3):275-82. PubMed ID: 3552016
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric quantitation of the c-myc oncoprotein in archival neoplastic biopsies of the colon.
Watson JV; Stewart J; Cox H; Sikora K; Evan GI
Mol Cell Probes; 1987 Jun; 1(2):151-7. PubMed ID: 3331172
[TBL] [Abstract][Full Text] [Related]
3. Oncogene expression in ovarian cancer: a pilot study of c-myc oncoprotein in serous papillary ovarian cancer.
Watson JV; Curling OM; Munn CF; Hudson CN
Gynecol Oncol; 1987 Oct; 28(2):137-50. PubMed ID: 3311922
[TBL] [Abstract][Full Text] [Related]
4. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
[TBL] [Abstract][Full Text] [Related]
5. A simultaneous flow cytometric assay for c-myc oncoprotein and DNA in nuclei from paraffin embedded material.
Watson JV; Sikora K; Evan GI
J Immunol Methods; 1985 Oct; 83(1):179-92. PubMed ID: 3902971
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric classification of biopsy specimens from cervical intraepithelial neoplasia.
Jakobsen A; Kristensen PB; Poulsen HK
Cytometry; 1983 Sep; 4(2):166-9. PubMed ID: 6628138
[TBL] [Abstract][Full Text] [Related]
7. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
[TBL] [Abstract][Full Text] [Related]
8. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
[TBL] [Abstract][Full Text] [Related]
9. Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tract.
van Dam PA; Lowe DG; Watson JV; James M; Chard T; Hudson CN; Shepherd JH
Gynecol Oncol; 1991 Sep; 42(3):256-64. PubMed ID: 1683331
[TBL] [Abstract][Full Text] [Related]
10. Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer.
Rowley S; Newbold KM; Gearty J; Keighley MR; Donovan IA; Neoptolemos JP
World J Surg; 1990; 14(4):545-50; discussion 551. PubMed ID: 2200214
[TBL] [Abstract][Full Text] [Related]
11. C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix.
Riou G; Barrois M; Lê MG; George M; Le Doussal V; Haie C
Lancet; 1987 Apr; 1(8536):761-3. PubMed ID: 2882179
[TBL] [Abstract][Full Text] [Related]
12. [Flow cytometry (FCM) in DNA content assay of normal and malignant epithelial cells of human uterine cervix and the prognostic significance of DNA content--II. Results].
Wu AR
Zhonghua Zhong Liu Za Zhi; 1988 May; 10(3):194-6. PubMed ID: 3219979
[TBL] [Abstract][Full Text] [Related]
13. c-myc oncogene product expression and prognosis in operable breast cancer.
Locker AP; Dowle CS; Ellis IO; Elston CW; Blamey RW; Sikora K; Evan G; Robins RA
Br J Cancer; 1989 Nov; 60(5):669-72. PubMed ID: 2679850
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of c-myc oncoprotein in non-small-cell lung carcinoma: comparison with immunohistochemical results.
De Santis L; Mangili F; Sassi I; Di Rocco M; Rossi C; Cantaboni A
Anal Cell Pathol; 1995 Apr; 8(3):247-57. PubMed ID: 7547497
[TBL] [Abstract][Full Text] [Related]
15. Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells.
Kastan MB; Stone KD; Civin CI
Blood; 1989 Oct; 74(5):1517-24. PubMed ID: 2506946
[TBL] [Abstract][Full Text] [Related]
16. c-myc oncogene expression and clinical outcome in carcinoma of the cervix.
Sowani A; Ong G; Dische S; Quinn C; White J; Soutter P; Waxman J; Sikora K
Mol Cell Probes; 1989 Jun; 3(2):117-23. PubMed ID: 2671679
[TBL] [Abstract][Full Text] [Related]
17. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
18. Quantification of the c-myc oncoprotein in human glioblastoma cells and tumor tissue.
Engelhard HH; Butler AB; Bauer KD
J Neurosurg; 1989 Aug; 71(2):224-32. PubMed ID: 2545843
[TBL] [Abstract][Full Text] [Related]
19. c-myc oncoprotein levels in bladder cancer.
Masters JR; Vesey SG; Munn CF; Evan GI; Watson JV
Urol Res; 1988; 16(5):341-4. PubMed ID: 3059654
[TBL] [Abstract][Full Text] [Related]
20. Comparison between flow cytometry and single cell cytophotometry for DNA content analysis of the uterine cervix.
Strang P; Lindgren A; Stendahl U
Acta Radiol Oncol; 1985; 24(4):337-41. PubMed ID: 2994391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
